Hormone therapy in peri- and postmenopause and the risk of cancer

Publisher： Govi-Verlag

ISSN： 2195-2175

Source： PHARMAKON, Vol.3, Iss.6, 2015-11, pp. : 455-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy

By Justenhoven Christina   Obazee Ofure   Brauch Hiltrud  

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 659-675

Future Medicine

Access to resources Recommend Favorite

Testosterone: Its Role in Development of Prostate Cancer and Potential Risk From Use as Hormone Replacement Therapy

By Slater S.   Oliver R.T.D.  

Drugs & Aging, Vol. 17, Iss. 6, 2000-12 ,pp. : 431-439

Adis International

Access to resources Recommend Favorite

Antihypertensive Therapy and Cancer Risk

By Felmeden D.C.   Lip G.Y.H.  

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 727-739

Adis International

Access to resources Recommend Favorite

Combined hormone therapy and cardiovascular, VTE risk

By  

Reactions Weekly, Vol. 1, Iss. 1161, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Combined hormone therapy and cardiovascular, VTE risk

By  

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite